Literature DB >> 9496937

Abnormal intestinal intraepithelial lymphocytes in refractory sprue.

C Cellier1, N Patey, L Mauvieux, B Jabri, E Delabesse, J P Cervoni, M L Burtin, D Guy-Grand, Y Bouhnik, R Modigliani, J P Barbier, E Macintyre, N Brousse, N Cerf-Bensussan.   

Abstract

BACKGROUND & AIMS: The etiology of refractory sprue is unclear. To gain insight into its pathogenesis, the phenotype and T-cell receptor (TCR) gene rearrangement status of intestinal lymphocytes were analyzed in a group of patients with clinical or biological features of celiac disease but either initially or subsequently refractory to a gluten-free diet.
METHODS: Intestinal biopsy specimens were obtained from 26 adults: 6 patients with refractory sprue, 7 patients with active celiac disease, and 13 normal controls. The phenotype of intestinal lymphocytes was studied by immunohistochemistry and, in 3 patients with refractory sprue, by cytometry of lymphocytes purified from intestinal biopsy specimens. TCR rearrangements were assessed by studying TCRgammaV-J junctional regions from DNA extracted from intestinal biopsy specimens and purified intestinal lymphocytes.
RESULTS: In the 6 patients with refractory sprue, but not in normal controls or patients with active celiac disease, the intestinal epithelium was massively infiltrated by small lymphocytes that lacked CD8, CD4, and TCR, contained intracytoplasmic but not surface CD3epsilon chains, and exhibited restricted TCRgamma gene rearrangements.
CONCLUSIONS: Refractory sprue is associated with an abnormal subset of intraepithelial lymphocytes containing CD3epsilon and restricted rearrangements of the TCRgamma chain but lacking surface expression of T-cell receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9496937     DOI: 10.1016/s0016-5085(98)70530-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  75 in total

Review 1.  Nongranulomatous chronic idiopathic enterocolitis: a primary histologically defined disease.

Authors:  K H Soergel
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

2.  Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease.

Authors:  A Di Sabatino; R Ciccocioppo; S D'Alò; R Parroni; D Millimaggi; M G Cifone; G R Corazza
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

3.  First steps in unraveling the genotype of enteropathy-type T-cell lymphoma.

Authors:  Ming-Qing Du; Peter G Isaacson
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 4.  Intraepithelial lymphocytes in celiac disease immunopathology.

Authors:  Valérie Abadie; Valentina Discepolo; Bana Jabri
Journal:  Semin Immunopathol       Date:  2012-06-03       Impact factor: 9.623

Review 5.  Refractory sprue.

Authors:  Andrea N Culliford; Peter H R Green
Journal:  Curr Gastroenterol Rep       Date:  2003-10

6.  From hyperplasia to T cell lymphoma.

Authors:  N Cerf-Bensussan; N Brousse; C Cellier
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 7.  CD4+ T-cell lymphoproliferative disorder of the gut clinically mimicking celiac sprue.

Authors:  Jaroslav Zivny; Barbara F Banner; Sanjay Agrawal; German Pihan; Graham F Barnard
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

Review 8.  Classification and management of refractory coeliac disease.

Authors:  Alberto Rubio-Tapia; Joseph A Murray
Journal:  Gut       Date:  2010-04       Impact factor: 23.059

9.  Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.

Authors:  A Al-Toma; W H M Verbeek; M Hadithi; B M E von Blomberg; C J J Mulder
Journal:  Gut       Date:  2007-04-30       Impact factor: 23.059

10.  Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression.

Authors:  I N Farstad; F-E Johansen; L Vlatkovic; J Jahnsen; H Scott; O Fausa; A Bjørneklett; P Brandtzaeg; T S Halstensen
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.